ACTH in Progressive Forms of MS
Treatment of Progressive Forms of Multiple Sclerosis With Pulsed ACTH (Acthar Gel)
Sponsor: Mallinckrodt
Terminated
The funding source discontinued financial support for the study.
This PHASE2 trial investigates Primary Progressive Multiple Sclerosis and Progressive Relapsing Multiple Sclerosis and is currently terminated or withdrawn. Mallinckrodt leads this study, which shows 15 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Mar 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Mar 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jun 2023 — Jul 2024 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Sep 2022 — Jun 2023 [monthly]
Active Not Recruiting PHASE2
▶ Show 10 earlier versions
-
Apr 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
-
Sep 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2
-
Jul 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Dec 2019 — Jul 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE2
-
Apr 2019 — Nov 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Apr 2019 [monthly]
Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Apr 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mallinckrodt
- University of Minnesota
For direct contact, visit the study record on ClinicalTrials.gov .